Defective glucose homeostasis during infection

Annual Review of Nutrition

Volumn 25, Issue , 2005, Pages 9-35

  McGuinness, Owen P ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Enteral nutrition; Glucagon; Gluconeogenesis; Hyperglycemia; Insulin resistance; Lactate; Nutritional support; Parenteral nutrition; Sepsis

Indexed keywords

GLUCOSE;

ACCELERATION; AMINO ACID METABOLISM; CARBOHYDRATE METABOLISM; DIETARY INTAKE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HORMONE RESPONSE; HYPERGLYCEMIA; INFECTION; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; NEUROENDOCRINE SYSTEM; NONHUMAN; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; PROTEIN METABOLISM; REVIEW; STRESS;

GLUCONEOGENESIS; GLUCOSE; HOMEOSTASIS; HORMONES; HUMANS; INFECTION; INFLAMMATION; INSULIN RESISTANCE; LIVER; NUTRITIONAL SUPPORT;

EID: 23944460509     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.24.012003.132159     Document Type: Review

References (171)

1. Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF. 2002. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 277:1531-37
2. Asher EF, Garrison RN, Ratcliff EJ, Fry DE. 1983. Endotoxin, cellular function, and nutrient blood flow. Arch. Surg. 118:441-45
3. Bagby GJ, Lang CH, Skrepnik N, Spitzer JJ. 1992. Attenuation of glucose metabolic changes resulting from TNF-alpha administration by adrenergic blockade. Am. J. Physiol. 262:R628-35
4. Barber AE, Jones WG 2nd, Minei JP, Fahey TJ 3rd, Lowry SF, Shires GT. 1991. Bacterial overgrowth and intestinal atrophy in the etiology of gut barrier failure in the rat. Am. J. Surg. 161:300-4
5. Barzilai N, Rossetti L. 1993. Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin. J. Biol. Chem. 268:25019-25
6. Bellomo R. 2002. Bench-to-bedside review: lactate and the kidney. Crit. Care 6:322-26
7. Bessey PQ, Aoki TT, Wilmore DW. 1985. Fuel utilization following injury: relationship to hormonal environment. J. Surg. Res. 38:484-93
8. Bessey PQ, Lowe KA. 1993. Early hormonal changes affect the catabolic response to trauma. Ann. Surg. 218:476-89
9. Biggers DW, Myers SR, Neal D, Stinson R, Cooper NB, et al. 1989. Role of brain in counterregulation of insulin-induced hypoglycemia in dogs. Diabetes 38:7-16
10. Buday AZ, Lang CH, Bagby GJ, Spitzer JJ. 1986. Glycogen synthase and phosphorylase activities during glycogen repletion in endotoxemic rats. Circ. Shock 19:149-63
11. Carlson GL. 2004. Hunterian Lecture. Insulin resistance in human sepsis: implications for the nutritional and metabolic care of the critically ill surgical patient. Ann. R. Coll. Surg. Engl. 86:75-81
12. Caruana JA, Camara DS, Schneeberger GJ, Nolan JP. 1984. The clearance capacity of the canine liver for a portal vein endotoxin infusion. J. Surg. Res. 37:197-201
13. Cely CM, Arora P, Quartin AA, Kett DH, Schein RM. 2004. Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness. Chest 126:879-87
14. Ceppi ED, Knowles RG, Carpenter KM, Titheradge MA. 1992. Effect of treatment in vivo of rats with bacterial endotoxin on fructose 2,6-biphosphate metabolism and L-pyruvate kinase activity and flux in isolated liver cells. Biochem. J. 284:761-66
15. Chen SS, Donmoyer C, Zhang Y, Hande SA, Lacy DB, McGuinness OP. 2000. Impact of enteral and parenteral nutrition on hepatic and muscle glucose metabolism. J. Parenter. Enteral Nutr. 24:255-60
16. Chen SS, Donmoyer CM, Ejiofor J, McCay J, Archuletta R, et al. 2002. Impact of intraportal N(omega)-nitro-L-arginine infusion on hepatic glucose metabolism in total parenteral nutrition-adapted dogs: interaction with infection. Metabolism 51:274-83
17. Chen SS, Donmoyer CM, Pearson DA, Poole A, Zhang Y, et al. 2004. Impact of infection on glucose-dependent liver glucose uptake during TPN: interaction with insulin. Am. J. Physiol. 286:E286-95
18. Chen Y-D, Swislocki ALM, Hellenbeck CB, Wu M-S, Reaven GM. 1988. Relationship between plasma glucose and insulin concentration, glucose production and glucose disposal in normal subjects and patients with non-insulin-dependent diabetes. J. Clin. Invest. 67:1084-89
19. Cherrington AD, Diamond MP, Green DR, Williams PE. 1982. Evidence for an intrahepatic contribution to the waning effect of glucagon on glucose production in the conscious dog. Diabetes 31:917-22
20. Cherrington AD, Wasserman DH, McGuinness OP. 1994. Renal contribution to glucose production after a brief fast: fact or fancy? J. Clin. Invest. 93:2303
21. Cherrington AD, Williams PE, Shulman GI, Lacy WW. 1981. Differential time course of glucagon's effect on glycogenolysis and gluconeogenesis in the conscious dog. Diabetes 30:180-87
22. Chhibber VL, Soriano C, Tayek JA. 2000. Effects of low-dose and high-dose glucagon on glucose production and gluconeogenesis in humans. Metabolism 49:39-46
23. Chrusch C, Bands C, Bose D, Li X, Jacobs H, et al. 2000. Impaired hepatic extraction and increased splanchnic production contribute to lactic acidosis in canine sepsis. Am. J. Respir. Crit. Care Med. 161:517-26
24. Chu CA, Galassetti P, Igawa K, Sindelar DK, Neal DW, et al. 2003. Interaction of free fatty acids and epinephrine in regulating hepatic glucose production in conscious dogs. Am. J. Physiol. 284:E291-301
25. Chu CA, Sindelar DK, Neal DW, Allen EJ, Donahue EP, Cherrington AD. 1997. Comparison of the direct and indirect effects of epinephrine on hepatic glucose production. J. Clin. Invest. 99:1044-56
26. Chu CA, Sindelar DK, Neal DW, Cherrington AD. 1996. Direct effects of catecholamines on hepatic glucose production in conscious dog are due to glycogenolysis. Am. J. Physiol. 271:E127-37
27. Chu CA, Sindelar DK, Neal DW, Cherrington AD. 1997. Portal adrenergic blockade does not inhibit the gluconeogenic effects of circulating catecholamines on the liver. Metabolism 46:458-65
28. Connolly CC, Stevenson RW, Neal DW, Wasserman DH, Cherrington AD. 1993. The effects of lactate loading on alanine and glucose metabolism in the conscious dog. Metabolism 42:154-61
29. Cornell RP, Filkins JP. 1974. Characterization of gluconeogenesis in enzymatically isolated parenchymal cells of rat liver. Proc. Soc. Exp. Biol. Med. 145:203-9
30. Dahn MS, Lange P. 1982. Hormonal changes and their influence on metabolism and nutrition in the critically ill. Intensive Care Med. 8:209-13
31. Davis SN, McGuinness OP, Cherrington AD. 1990. Insulin action in vivo. In Diabetes Annual IV, ed. KGMM Alberti, LP Krall, pp. 585-602. Amsterdam: Elsevier Sci.
32. De Backer D, Creteur J, Silva E, Vincent JL. 2001. The hepatosplanchnic area is not a common source of lactate in patients with severe sepsis. Crit. Care Med. 29:256-61
33. Defalque D, Brandt N, Ketelslegers JM, Thissen JP. 1999. GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors. Am. J. Physiol. 276:E565-72
34. Defronzo RA, Ferrannini E, Simonson DC. 1989. Fasting hyperglycemia in non-insulin dependent diabetes mellitus: contribution of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387-91
35. Deitch EA. 1992. Multiple organ failure pathophysiology and potential future therapy. Ann. Surg. 216:117-34
36. Deitch EA, Xu D, Franko L, Ayala A, Chaudry IH. 1995. Evidence favoring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock. Shock 1:141-46
37. DeWulf H, Hers HG. 1968. The interconversion of liver glycogen synthase a and b in vitro. Eur. J. Biochem. 6:552-57
38. Diamond MP, Rollings RC, Steiner KE, Williams PE, Lacy WW, Cherrington AD. 1988. Effect of alanine concentration independent of changes in insulin and glucagon on alanine and glucose homeostasis in the conscious dog. Metabolism 37:28-33
39. Diamond MP, Suhrer JH Jr, Williams PE, Lacy WW, Cherrington AD. 1982. Contribution of the liver and extrasplanchnic tissues to the hypoglycemic action of dichloroacetate in the conscious dog. Diabetes 31:(Pt 1):326-32
40. Donmoyer CM, Chen S-S, Hande SA, Lacy DB, Ejiofor J, McGuinness OP. 2000. Hyperinsulinemia compensates for infection-induced impairment in net hepatic glucose uptake during TPN. Am. J. Physiol. 279:E235-43
41. Donmoyer CM, Chen S-S, Lacy DB, Pearson DA, Poole A, et al. 2003. Infection impairs insulin-dependent hepatic glucose uptake during total parenteral nutrition. Am. J. Physiol. 284:E574-82
42. Donmoyer CM, Ejiofor J, Lacy DB, Chen S-S, McGuinness OP. 2001. Fructose augments infection-impaired net hepatic glucose uptake during TPN administration. Am. J. Physiol. 280:E703-11
43. Donmoyer CM, Lacy DB, Zhang Y, Chen S-S, McGuinness OP. 2002. Impact of chronic fructose infusion on hepatic metabolism during TPN administration. Am. J. Physiol. 283:E1151-58
44. Engelman JA, Berg AH, Lewis RY, Lisanti MP, Scherer PE. 2000. Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes. Mol. Endocrinol. 14:1557-69
45. Fairman RM, Crosby LO, Stein TP, Buzby GP, Mullen JL. 1983. Prehepatic total parenteral nutrition in the chair-adapted primate. J. Parenter. Enteral Nutr. 7:237-43
46. Feuerstein G, Hallenbeck JM, Vanatta B, Rabinovici R, Perera PY, Vogel SN. 1990. Effects of gram-negative endotoxin on levels of serum corticosterone, TNFα, circulating blood cells, and the survival of rats. Circ. Shock 30:265-78
47. Filkins JP, Cornell RP. 1974. Depression of hepatic gluconeogenesis and the hypoglycemia of endotoxin shock. Am. J. Physiol. 227:778-81
48. Finney SJ, Zekveld C, Elia A, Evans TW. 2003. Glucose control and mortality in critically ill patients. JAMA 290:2041-47
49. Fong YM, Marano MA, Moldawer LL, Wei H, Galvano SE, et al. 1990. The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J. Clin. Invest. 85:1896-904
50. Frost RA, Nystrom GJ, Lang CH. 2002. Lipopolysaccharide regulates proinflammatory cytokine expression in mouse myoblasts and skeletal muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283: R698-709
51. Fujiwara T, Cherrington AD, Neal DW, McGuinness OP. 1996. Role of cortisol in the metabolic response to stress hormone infusion in the conscious dog. Metabolism 45:571-78
52. Galassetti P, Shiota M, Zinker BA, Wasserman DH, Cherrington AD. 1998. A negative arterial-portal venous glucose gradient decreases skeletal muscle glucose uptake. Am. J. Physiol. 275:E101-11
53. Cannon MC, Nuttall FQ. 1997. Effect of feeding, fasting, and diabetes on liver glycogen synthase activity, protein, and mRNA in rats. Diabetologia 40:758-63
54. Gelfand RA, Matthews DE, Bier DM, Sherwin RS. 1984. Role of counterregulatory hormones in the catabolic response to stress. J. Clin. Invest. 74:2238-48
55. Gibson FA, Hinds CJ. 1997. Growth hormone and insulin-like growth factors in critical illness. Int. Care Med. 23:369-78
56. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. 1999. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 22:1408-14
57. Goldstein R, Palmer B, Liu R, Massillon D. 1995. The effects of chronic hypercortisolemia on gluconeogenesis assessed using two independent methods in vivo. Diabetes 44(Suppl. 1):201
58. Goldstein RE, Wasserman DH, McGuinness OP, Lacy DB, Cherrington AD, Abumrad NN. 1993. Effects of chronic elevation in plasma cortisol on hepatic carbohydrate metabolism. Am. J. Physiol. 264:E119-27
59. Gore DC, Jahoor F, Hibbert JM, DeMaria EJ. 1996. Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Ann. Surg. 224:97-102
60. Gustavson SM, Chu CA, Nishizawa M, Fanner B, Neal D, et al. 2003. Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog. Am. J. Physiol. Endocrinol. Metab. 284:E695-707
61. Gustavson SM, Chu CA, Nishizawa M, Farmer B, Neal D, et al. 2003. Glucagon's actions are modified by the combination of epinephrine and gluconeogenic precursor infusion. Am. J. Physiol. Endocrinol. Metab. 285:E534-44
62. Hadfield RJ, Sinclair DG, Houldsworth PE, Evans TW. 1995. Effects of enteral and parenteral nutrition on gut mucosal permeability in the critically ill. Am. J. Respir. Crit. Care Med. 152:1545-48
63. Hargrove DM, Bagby GJ, Lang CH, Spitzer JJ. 1988. Adrenergic blockade does not abolish elevated glucose turnover during bacterial infection. Am. J. Physiol. 254:E16-22
64. Hargrove DM, Bagby GJ, Lang CH, Spitzer JJ. 1988. Adrenergic blockade prevents endotoxin-induced increases in glucose metabolism. Am. J. Physiol. 255: E629-35
65. Hellerstein MK. 1999. De novo lipogenesis in humans: metabolic and regulatory aspects. Eur. J. Clin. Nutr. 53(Suppl. 1):53-65
66. Holste LC, Connolly CC, Moore MC, Neal DW, Cherrington AD. 1997. Physiological changes in circulating glucagon alter hepatic glucose disposition during portal glucose delivery. Am. J. Physiol. 273:E488-96
67. Horton RA, Knowles RG, Titheradge MA. 1994. Endotoxin causes reciprocal changes in hepatic nitric oxide synthesis, gluconeogenesis, and flux through phosphoenolpyruvate carboxykinase. Biochem. Biophys. Acta 204:659-65
68. Hotamisligil GS. 2003. Inflammatory pathways and insulin action. Int. J. Obes. Relat. Metab. Disord. 27(Suppl. 3):53-55
69. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. 1994. Tumor necrosis factor-α inhibits signaling from the insulin receptor. Proc. Natl. Acad. Sci. USA 91:4854-58
70. Ishida T, Lewis RM, Hartley CJ, Entman ML, Field JB. 1978. Comparison of hepatic extraction of insulin and glucagon in conscious dogs. Endocrinology 112:1098-109
71. Jacobs DO, Maris J, Fried R, Settle RG, Rolandelli RR, et al. 1988. In vivo phosphorus 31 magnetic resonance spectroscopy of rat hind limb skeletal muscle during sepsis. Arch. Surg. 123:1425-28
72. Jahoor F, Herdon DN, Wolfe RR. 1986. Role of insulin and glucagon in the response of glucose and alanine kinetics in burn-injured patients. J. Clin. Invest. 78:807-14
73. Jahoor F, Peters EJ, Wolfe RR. 1990. The relationship between gluconeogenic substrate supply and glucose production in humans. Am. J. Physiol. 258:E288-96
74. Johnson TS, O'Leary M, Justice SK, Maamra M, Zarkesh-Esfahani SH, et al. 2001. Differential expression of suppressors of cytokine signalling genes in response to nutrition and growth hormone in the septic rat. J. Endocrinol. 169:409-15
75. Kilberg MS, Stevens BR, Novak DA. 1993. Recent advances in mammalian amino acid transport. Annu. Rev. Nutr. 13:137-65
76. Kim HJ, Higashimori T, Park SY, Choi H, Dong J, et al. 2004. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 53:1060-67
77. King WWK, Boelhouwer RU, Kingsworth AN, Ross JS, Young VR, Malt RA. 1983. Nutritional efficacy and hepatic changes during intragastric, intravenous and prehepatic feeding in rats. J. Parenter. Enteral Nutr. 7:443-46
78. Klover PJ, Zimmers TA, Koniaris LG, Mooney RA. 2003. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 52:2784-89
79. Krogh-Madsen R, Moller K, Dela F, Kronborg G, Jauffred S, Pedersen BK. 2004. Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans. Am. J. Physiol. Endocrinol. Metab. 286:E766-72
80. Kudsk KA, Whitnal M, Abrams JS, Mougey EH. 1993. Enteral and tumor necrosis factor in normal rats. J. Trauma 132:946-52
81. Landau BR. 1999. Quantifying the contribution of gluconeogenesis to glucose production in fasted human subjects using stable isotopes. Proc. Nutr. Soc. 58:963-72
82. Lang CH. 1992. Sepsis-induced insulin resistance in rats is mediated by a beta-adrenergic mechanism. Am. J. Physiol. 263:E703-11
83. Lang CH. 1993. Beta-adrenergic blockade attenuates insulin resistance induced by tumor necrosis factor. Am. J. Physiol. 264:R984-91
84. Lang CH. 2001. Sepsis-induced changes in pancreatic hormone secretion. In Handbook of Physiology: The Endocrine Pancreas and Regulation of Metabolism, ed. LS Jefferson, AD Cherrington, pp. 999-1014. New York: Oxford Univ. Press
85. Lang CH, Bagby GJ, Blakesley HL, Spitzer JJ. 1987. Fever is not responsible for the elevated glucose kinetics in sepsis. Proc. Soc. Exp. Biol. Med. 185:455-61
86. Lang CH, Bagby GJ, Blakesley HL, Spitzer JJ. 1987. Glucose kinetics and pyruvate dehydrogenase activity in septic rats treated with dichloroacetate. Circ. Shock 23:131-41
87. Lang CH, Bagby GJ, Blakesley HL, Spitzer JJ. 1987. Inhibition of eicosanoid production by BW755C does not attenuate sepsis-induced alterations in glucose kinetics. Circ. Shock 22:105-13
88. Lang CH, Bagby GJ, Blakesley HL, Spitzer JJ. 1989. Importance of hyperglucagonemia in eliciting the sepsis-induced increase in glucose production. Circ. Shock 29:181-91
89. Lang CH, Bagby GJ, Buday AZ, Spitzer JJ. 1987. The contribution of gluconeogenesis to glycogen repletion during glucose infusion in endotoxemia. Metabolism 36:180-87
90. Lang CH, Bagby GJ, Spitzer JJ. 1984. Carbohydrate dynamics in the hypermetabolic septic rat. Metabolism 33:959-63
91. Lang CH, Bagby GJ, Spitzer JJ. 1985. Glucose kinetics and body temperature after lethal and nonlethal doses of endotoxin. Am. J. Physiol. 248:R471-78
92. Lang CH, Blakesley HL, Bagby GJ, Spitzer JJ. 1988. Lipoxygenase and cyclooxygenase blockade by BW755C prevents endotoxin-induced hypotension but not changes in glucose metabolism. Horm. Metab. Res. 20:551-54
93. Lang CH, Dobrescu C. 1989. In vivo insulin resistance during nonlethal hypermetabolic sepsis. Circ. Shock 28:165-78
94. Lang CH, Dobrescu C. 1989. Interleukin-1 induced increases in glucose utilization are insulin mediated. Life Sci. 45:2127-34
95. Lang CH, Dobrescu C. 1989. Sepsis-induced changes in in vivo insulin action in diabetic rats. Am. J. Physiol. 257(Pt. 1): E301-8
96. Lang CH, Dobrescu C. 1991. Gram-negative infection increases noninsulin-mediated glucose disposal. Endocrinology 128:645-53
97. Lang CH, Dobrescu C, Bagby GJ. 1992. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130:43-52
98. Lang CH, Dobrescu C, Meszaros K. 1990. Insulin-mediated glucose uptake by individual tissues during sepsis. Metabolism 39:1096-107
99. Lang CH, Obih JA, Bagby GJ, Bagwell JN, Spitzer JJ. 1991. Endotoxin-induced increases in regional glucose utilization by small intestine: a TNF-independent effect. Am. J. Physiol. 260(Pt. 1):G548-55
100. Lecavalier L, Bolli G, Gerich J. 1990. Glucagon-cortisol interactions on glucose turnover and lactate gluconeogenesis in normal humans. Am. J. Physiol. 258:E569-75
101. Lipman TO. 1998. Grains or veins: Is enteral nutrition really better than parenteral nutrition? A look at the evidence. J. Parenter. Enteral Nutr. 22:167-82
102. Long CL, Kinney JM, Geiger JW. 1976. Nonsuppressability of gluconeogenesis by glucose in septic patients. Metabolism 25:193-201
103. Long CL, Spencer JL, Kinney JM, Geiger JW. 1971. Carbohydrate metabolism in man: effect of elective operations and major injury. J. Appl. Physiol. 31:110-16
104. Magnusson I, Rothman DL, Gerard DP, Katz LD, Shulman GI. 1995. Contribution of hepatic glycogenolysis to glucose production in humans in response to a physiological increase in plasma glucagon concentration. Diabetes 44:185-89
105. McCallum RE, Seale TW, Stith RD. 1983. Influence of endotoxin treatment on dexamethasone induction of hepatic phosphoenolpyruvate carboxykinase. Infect. Immun. 39:213-19
106. McGuinness OP. 1994. The impact of infection on gluconeogenesis in the conscious dog. Shock 2:336-43
107. McGuinness OP, Burgin K, Moran C, Bracy D, Cherrington AD. 1994. Role of glucagon in the metabolic response to stress hormone infusion in the conscious dog. Am. J. Physiol. 266:E438-47
108. McGuinness OP, Donmoyer CM, Ejiofor J, McElligott S, Lacy DB. 1998. Hepatic and muscle glucose metabolism during total parenteral nutrition: impact of infection. Am. J. Physiol. 275:E763-69
109. McGuinness OP, Ejiofor J, Audoly LP, Schrom N. 1998. Regulation of glucose production by NEFA and gluconeogenic precursors during chronic glucagon infusion. Am. J. Physiol. 275:E432-39
110. McGuinness OP, Ejiofor J, Lacy DB, Schrom N. 2000. Hepatic glucose metabolism during intraduodenal glucose infusion: impact of infection. Am. J. Physiol. 279:E108-15
111. McGuinness OP, Fujiwara T, Murrell S, Bracy D, Neal D, et al. 1993. Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog. Am. J. Physiol. 265:E314-22
112. McGuinness OP, Jacobs J, Moran C, Lacy DB. 1995. Impact of infection on hepatic disposal of a peripheral glucose infusion in the conscious dog. Am. J. Physiol. 269:E199-207
113. McGuinness OP, Lacy DB, Anderson J. 1995. Effect of acute glucagon removal on metabolic response to infection in conscious dog. Am. J. Physiol. 268:E92-99
114. McGuinness OP, Lacy DB, Eliasson KE. 1996. Hyperglucagonemia and hepatic glucose metabolism during infection in the conscious dog. Am. J. Physiol. 270: E580-86
115. McGuinness OP, Murrell S, Moran C, Bracy D, Cherrington AD. 1994. The effect of acute glucagon removal on the metabolic response to stress hormone infusion in the conscious dog. Metabolism 43:1310-17
116. McGuinness OP, Shau V, Benson EM, Lewis M, Snowden RT, et al. 1997. Role of epinephrine and norepinephrine in the metabolic response to stress hormone infusion in the conscious dog. Am. J. Physiol. 273:E674-81
117. McGuinness OP, Snowden RT, Moran C, Neal DW, Fujiwara T, Cherrington AD. 1999. Impact of acute epinephrine removal on hepatic glucose metabolism during stress hormone infusion. Metabolism 48:910-14
118. McMahon MM, Rizza RA. 1996. Nutrition support in hospitalized patients with diabetes mellitus. Mayo Clin. Proc. 71:587-94
119. Meinz HM, Lacy DB, Ejiofor J, McGuinness OP. 1998. Alterations in hepatic gluconeogenic amino acid uptake and gluconeogenesis in the endotoxin-treated conscious dog. Shock 9:296-303
120. Meszaros K, Lang CH, Bagby GJ, Spitzer JJ. 1987. Contribution of different organs to increased glucose consumption after endotoxin administration. J. Biol. Chem. 262:10965-70
121. Meszaros K, Lang CH, Bojta J, Spitzer JJ. 1989. Early changes in glucose utilization of individual tissues after endotoxin administration. Circ. Shock 29:107-14
122. Moore MC, Hsieh PS, Flakoll PJ, Neal DW, Cherrington AD. 1999. Differential effect of amino acid infusion route on net hepatic glucose uptake in the dog. Am. J. Physiol. 276:E295-302
123. Morikawa S, Inubushi T, Takahashi K, Ishii H, Ozawa K. 1998. Gluconeogenesis and phosphoenergetics in rat liver during endotoxemia. J. Surg. Res. 74:179-86
124. Myers SR, Biggers DW, Neal DW, Cherrington AD. 1991. Intraportal glucose delivery enhances the effects of hepatic glucose load on net hepatic glucose uptake in vivo. J. Clin. Invest. 88:158-67
125. Myers SR, McGuinness OP, Neal DW, Cherrington AD. 1991. Intraportal glucose delivery alters the relationship between net hepatic glucose uptake and the insulin concentration. J. Clin. Invest. 87:930-39
126. Neimeyer H, Ureta T, Clark-Turri L. 1975. Adaptive character of liver glucokinase. Mol. Cell Biochem. 6:109-26
127. Pagliassotti MJ, Cherrington AD. 1992. Regulation of net hepatic glucose uptake in vivo. Annu. Rev. Physiol. 54:847-60
128. Piccone VA, LeVeen HH, Glass P, Berlyne G, Lundin AP. 1980. Prehepatic hyperalimentation. Surgery 87:263-70
129. Pilkis SJ. 1970. Hormonal control of hexokinase activity in animal tissues. Biochim. Biophys. Acta 215:461-76
130. Pilkis SJ, el-Maghrabi MR, Claus TH. 1988. Hormonal regulation of hepatic gluconeogenesis and glycolysis. Annu. Rev. Biochem. 57:755-83
131. Pilkis SJ, Granner DK. 1992. Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu. Rev. Physiol. 54:885-909
132. Pittner RA, Spitzer JA. 1993. Shift from alpha- to beta-type adrenergic receptor-mediated responses in chronically endotoxemic rats. Am. J. Physiol. 264:E650-54
133. Reithmann C, Hallstrom S, Pilz G, Kapsner T, Schlag G, Werdan K. 1993. Desensitization of rat cardiomyocyte adenylyl cyclase stimulation by plasma of noradrenaline-treated patients with septic shock. Circ. Shock 41:48-59
134. Saeed M, Carlson GL, Little RA, Irving MH. 1999. Selective impairment of glucose storage in human sepsis. Br. J. Surg. 86:813-21
135. Saito H, Trocki O, Alexander JW, Kopcha R, Heyd T, Joffe SN. 1987. The effect of route of nutrient administration on the nutritional state, catabolic hormone secretion, and gut mucosal integrity after burn injury. J. Parenter. Enteral Nutr. 11:1-7
136. Santos AA, Scheltinga MR, Lynch E, Brown EF, Lawton P, et al. 1993. Elaboration of interleukin 1-receptor antagonist is not attenuated by glucocorticoids after endotoxemia. Arch. Surg. 128:138-43
137. Seoane J, Barbera A, Telemaque-Potts S, Newgard CB, Guinovart JJ. 1999. Glucokinase overexpression restores glucose utilization and storage in cultured hepatocytes from male Zucker diabetic fatty rats. J. Biol. Chem. 274:31833-38
138. Severin PN, Uhing MR, Beno DW, Kimura RE. 2002. Endotoxin-induced hyperlactatemia results from decreased lactate clearance in hemodynamically stable rats. Crit. Care Med. 30:2509-14
139. Shamoon H, Hendler R, Sherwin RS. 1981. Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans. J. Clin. Endocrinol. Metab. 52:1235-41
140. Shangraw RE, Jahoor F, Wolfe RR, Lang CH. 1996. Hunterian lecture: insulin resistance in human sepsis-induced insulin resistance. Crit. Care Med. 24:75-81
141. Shangraw RE, Jahoor F, Wolfe RR, Lang CH. 1996. Pyruvate dehydrogenase inactivity is not responsible for sepsis-induced insulin resistance. Crit. Care Med. 24:566-74
142. Shaw JH, Wolfe RR. 1985. Response to glucose and lipid infusions in sepsis: a kinetic analysis. Metabolism 34:442-49
143. Shaw JHF, Klein S, Wolfe RR. 1985. Assessment of alanine, urea and glucose interrelationships in normal subjects and in patients with sepsis with stable isotopes. Surgery 97:557-67
144. Sidossis LS, Mittendorfer B, Chinkes D, Waiser E, Wolfe RR. 1999. Effect of hyperglycemia-hyperinsulinemia on whole body and regional fatty acid metabolism. Am. J. Physiol. 276:E427-34
145. Sidossis LS, Mittendorfer B, Walser E, Chinkes D, Wolfe RR. 1998. Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion. Am. J. Physiol. 275:E798-805
146. Sigurdsson GH. 1995. Is translocation of bacteria and endotoxin from the gastrointestinal tract a source of sepsis in critically ill patients? Acta Anaes. Scand. 39:11-19
147. Sindelar DK, Chu CA, Rohlie M, Neal DW, Swift LL, Cherrington AD. 1997. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes 46:187-96
148. Soop M, Duxbury H, Agwunobi AO, Gibson JM, Hopkins SJ, et al. 2002. Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. Am. J. Physiol. 282: E1276-85
149. Spitzer JA, Nelson KM, Fish RE. 1985. Time course of changes in gluconeogenesis from various precursors in chronically endotoxemic rats. Metabolism 34:842-49
150. Spitzer JJ, Bagby GJ, Hargrove DM, Lang CH, Meszaros K. 1989. Alterations in the metabolic control of carbohydrates in sepsis. Prog. Clin. Biol. Res. 308:545-61
151. Spolarics Z, Bagby GJ, Lang CH, Spitzer JJ. 1991. Up-regulation of glucose metabolism in Kupffer cells following infusion of tumour necrosis factor. Biochem. J. 278:515-19
152. Stagnaro-Green A, Barton MK, Linekin PL, Corkery E, deBeer K, Roman SH. 1995. Mortality in hospitalized patients with hypoglycemia and severe hyperglycemia. Mt. Sinai J. Med. 62:422-26
153. Stevenson RW, Steiner KE, Connolly CC, Fuchs H, Alberti KG, et al. 1991. Dose-related effects of epinephrine on glucose production in conscious dogs. Am. J. Physiol. 260:E363-70
154. Stevenson RW, Steiner KE, Davis MA, Hendrick GK, Williams PE, et al. 1987. Similar dose responsiveness of hepatic glycogenolysis and gluconeogenesis to glucagon in vivo. Diabetes 36:382-89
155. Tappy L, Cayeux M, Schneller P, Schindler C, Temler E, et al. 1995. Effect of lactate on glucose metabolism in healthy subjects and severely injured hyperglycemic patients. Am. J. Physiol. 268:E630-35
156. Thompson WA, Coyle S, Van Zee K, Oldenburg H, Trousdale R, et al. 1994. The metabolic effects of platelet-activating factor antagonism in endotoxemic man. Arch. Surg. 129:72-79
157. Ueki K, Kondo T, Kahn CR. 2004. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol. Cell Biol. 24:5434-46
158. Ueki K, Kondo T, Tseng YH, Kahn CR. 2004. Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc. Natl. Acad. Sci. USA 101:10422-27
159. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. 2002. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J. Clin. Endocrinol. Metab. 87:978-82
160. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, et al. 2001. Intensive insulin therapy in the critically ill patients. N. Engl. J. Med. 345:1359-67
161. Vranic M, Engerman R, Doi K, Monta S, Yip CC. 1976. Extrapancreatic glucagon in the dog. Metabolism 25:1469-73
162. Wang K, Deutschman CS, Clemens MG, De Maio A. 1995. Reciprocal expression of phosphoenolpyruvate carboxykinase and acute phase genes during acute inflammation. Shock 3:204-9
163. White RH, Frayn KN, Little RA, Threlfall CJ, Stoner HB, Irving MH. 1987. Hormonal and metabolic responses to glucose infusion in sepsis studies by the hyperglycemia glucose clamp technique. J. Parenter. Enteral Nutr. 11:345-53
164. Wolfe RR. 1999. Sepsis as a modulator of adaptation to low and high carbohydrate and low and high fat intakes. Eur. J. Clin. Nutr. 53:5136-42
165. Wolfe RR, Elahi D, Spitzer JJ. 1977. Glucose and lactate kinetics after endotoxin administration in dogs. Am. J. Physiol. 232:E180-85
166. Wolfe RR, Herndon DN, Jahoor F, Miyoshi H, Wolfe M. 1987. Effect of severe burn injury on substrate cycling by glucose and fatty acids. N. Engl. J. Med. 317:403-8
167. Wolfe RR, Jahoor F, Shaw JH. 1987. Effect of alanine infusion on glucose and urea production in man. J. Parenter. Enteral Nutr. 11:109-11
168. Wolfe RR, Shaw JH. 1985. Glucose and FFA kinetics in sepsis: role of glucagon and sympathetic nervous system activity. Am. J. Physiol. 248:E236-43
169. Wolfe RR, Shaw JH, Durkot MJ. 1983. Energy metabolism in trauma and sepsis: the role of fat. Prog. Clin. Biol. Res. 111:89-109
170. Yki-Jarvinen H. 1993. Action of insulin on glucose metabolism in vivo. Baillieres Clin. Endocrinol. Metab. 7:903-27
171. Ziegler TR, Gatzen C, Wilmore DW. 1994. Strategies for attenuating protein-catabolic responses in the critically ill. Annu. Rev. Med. 45:459-80